Simvastatin regulates non-neuronal cholinergic activity in T lymphocytes via CD11a-mediated pathways

Journal of Neuroimmunology

Volumn 179, Issue 1-2, 2006, Pages 101-107

  Fujii, Takeshi ^a,b   Masuyama, Kazuto ^a   Kawashima, Koichiro ^a  

^a KEIO UNIVERSITY   (Japan)

^b DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

Author keywords

Acetylcholine; CD11a; Choline acetyltransferase; Lymphocyte function associated antigen 1; Simvastatin; T lymphocyte

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; MONOCLONAL ANTIBODY; MUSCARINIC M5 RECEPTOR; SIMVASTATIN;

ACETYLCHOLINE RELEASE; ARTICLE; CANCER CELL CULTURE; CELL ACTIVITY; CELL LINE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; T LYMPHOCYTE;

ACETYLCHOLINE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD11A; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLINE O-ACETYLTRANSFERASE; GENE EXPRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEVALONIC ACID; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIMVASTATIN; T-LYMPHOCYTES;

EID: 33748970483     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.05.029     Document Type: Article

References (42)

1. Bock H.A., Gallati H., Zurcher R.M., Bachofen M., Mihatsch M.J., Landmann J., and Thiel G. A randomized prospective trial of prophylactic immunosuppression with ATG-Fresenius versus OKT-3 after renal transplantation. Transplantation 59 (1995) 830-840
2. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72 (1976) 248-254
3. Carreno B.M., and Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20 (2002) 29-53
4. Carrera A.C., Rincon M., Sanchez-Madrid F., Lopez-Botet M., and deLandazuri M.O. Triggering of comitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3 and CD7 monoclonal antibodies. J. Immunol. 141 (1988) 1919-1924
5. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24 (1975) 407-409
6. Fouladi M., Herman R., Rolland-Grinton M., Jones-Wallence D., Blanchette V., Calderwood S., Doyle J., Halperin D., Leaker M., Sauders E.F., Zipursky A., and Freedman M.H. Improved survival in severe acquired aplastic anemia of childhood. Bone Marrow Transplant. 26 (2000) 1149-1156
7. Fujii T., and Kawashima K. Calcium oscillation is induced by muscarinic acetylcholine receptor stimulation in human leukemic T- and B-cell lines. Naunyn-Schmiedeberg's Arch. Pharmacol. 362 (2000) 14-21
8. 3 muscarinic acetylcholine receptors in human T- and B-cells. Jpn. J. Pharmacol. 84 (2000) 124-132
9. 2+ signaling and c-fos gene expression mediated via muscarinic receptors in human T cells. Gen. Pharmacol. 35 (2001) 71-75
10. Fujii T., and Kawashima K. The non-neuronal cholinergic system: an independent non-neuronal cholinergic system in lymphocytes. Jpn. J. Pharmacol. 85 (2001) 11-15
11. Fujii, T., Kawashima, K., 2003. Activation of an independent, non-neuronal cholinergic system in T lymphocytes via three different pathways. Prog. No. 710.3. 2003 Abstract Viewer and Itinerary Planner. New Orleans, Society for Neuroscience, 2003. CD-ROM.
12. Fujii T., Yamada S., Misawa H., Tajima S., Fujimoto K., Suzuki T., and Kawashima K. Expression of choline acetyltransferase mRNA and protein in T-lymphocytes. Proc. Jpn. Acad. 71B (1995) 231-235
13. Fujii T., Tsuchiya T., Yamada S., Fujimoto K., Suzuki T., Kasahara T., and Kawashima K. Localization and synthesis of acetylcholine in human leukemic T-cell lines. J. Neurosci. Res. 44 (1996) 66-72
14. Fujii T., Yamada S., Watanabe Y., Misawa H., Tajima S., Fujimoto K., Kasahara T., and Kawashima K. Induction of choline acetyltransferase mRNA in human mononuclear leukocytes stimulated by phytohemagglutinin, a T-cell activator. J. Neuroimmunol. 82 (1998) 101-107
15. Fujii T., Tajima S., Yamada S., Watanabe Y., Sato K.Z., Matsui M., Misawa H., Kasahara T., and Kawashima K. Constitutive expression of mRNA for the same choline acetyltransferase as that in the nervous system, an acetylcholine-synthesizing enzyme, in human leukemic T-cell lines. Neurosci. Lett. 259 (1999) 71-74
16. Fujii T., Ushiyama N., Hosonuma K., Suenaga A., and Kawashima K. Effects of human antithymocyte globulin on acetylcholine synthesis, its release and choline acetyltransferase transcription in a human leukemic T-cell line. J. Neuroimmunol. 128 (2002) 1-8
17. 5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses. Neurochem. Res. 28 (2003) 423-429
18. Horiuchi Y., Fujii T., Kamimura Y., and Kawashima K. The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responses. J. Neuroimmunol. 144 (2003) 46-52
19. Kanner S.B., Grosmaire L.S., Ledbetter J.A., and Damle N.K. β2-integrin LFA-1 signaling through phospholipase C-γ1 activation. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7099-7103
20. Kawashima K., and Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther. 86 (2000) 29-48
21. Kawashima K., and Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 74 (2003) 675-696
22. Kawashima K., and Fujii T. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front. Biosci. 9 (2004) 2063-2085
23. Kawashima K., Ishikawa H., and Mochizuki M. Radioimmunoassay for acetylcholine in the rat brain. J. Pharmacol. Methods 3 (1980) 115-123
24. 2+ signaling and down-regulation of nicotine acetylcholine receptor subunit expression in the CEM human leukemic T-cell line. Life Sci. 72 (2003) 2155-2158
25. Kobashigawa J.A., Katznelson S., Laks H., Johnson J.A., Yeatman L., Wang X.M., Chia D., Terasaki P.I., Sabad A., Cogert G.A., Trosian K., Hamilton M.A., Moriguchi J.D., Kawata N., Hage A., Drinkwater D.C., and Stevenson L.W. Effect of pravastatin on outcomes after cardiac transplantation. N. Engl. J. Med. 333 (1995) 621-627
26. Kojima S., Horibe K., Inaba J., Yoshimi A., Takahashi Y., Kudo K., Kato K., and Matsuyama T. Long-term outcome of acquired aplastic anemia in children: comparison between immunosuppressive therapy and bone marrow transplantation. Br. J. Haematol. 111 (2000) 321-328
27. Ledbetter J.A., June C.H., Grosmaire L.S., and Rabinnovitch P.S. Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 1384-1388
28. Leta E., Roy A.K., Hou Z., and Jung L.K. Production and characterization of the extracellular domain of human CD7 antigen: further evidence that CD7 has a role in T cell signaling. Cell. Immunol. 165 (1995) 101-109
29. Meyers C.D., Tannock L.R., Wight T.N., and Chait A. Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL. J. Lipid Res. 44 (2003) 2152-2160
30. Neuhaus O., Stuve O., Zamvil S.S., and Haartung H.P. Are statins a treatment option for multiple sclerosis. Lancet Neurol. 3 (2004) 369-371
31. Oosawa H., Fujii T., and Kawashima K. Nerve growth factor increases the synthesis and release of acetylcholine and the expression of vesicular acetylcholine transporter in primary cultured rat embryonic septal cells. J. Neurosci. Res. 57 (1999) 381-387
32. Paldi-Haris P., Szelenyi J.G., Nguyen T.H., and Hollan S.R. Changes in the expression of the cholinergic structures of human T lymphocytes due to maturation and stimulation. Thymus 16 (1990) 119-122
33. Passweg J., Thiel G., and Bock H.A. Monoclonal gammopathy after intense induction immunosuppression in renal transplant patients. Nephrol. Dial. Transplant. 11 (1996) 2461-2465
34. Remberger M., Svahn B.M., Heutschke P., Lofgren C., and Ringden O. Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation. Bone Marrow Transplant. 24 (1999) 823-830
35. Sato K.Z., Fujii T., Watanabe Y., Yamada S., Ando T., Fujimoto K., and Kawashima K. Diversity of mRNA for muscarinic acetylcholine receptor subtypes and neuronal acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci. Lett. 266 (1999) 17-20
36. 4 receptor agonist, in MOLT-3 human leukemic T cells. Vasc. Pharmacol. 41 (2004) 51-58
37. Szelenyi J., Paldi-Haris P., and Hollan S. Changes in the cholinergic system of lymphocytes due to mitogenic stimulation. Immunol. Lett. 16 (1987) 49-54
38. Tisdale J.F., Dunn D.E., Geller N., Plante M., Nunez O., Dunbar C.E., Barrett A.J., Walsh T.J., Rosenfeld S.J., and Young N.S. High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet 356 (2000) 1554-1559
39. Tuček S. The synthesis of acetylcholine in skeletal muscles of the rat. J. Physiol. 322 (1982) 53-69
40. Wanner C., Quaschning T., and Weingarnter K. Impact of dyslipidaemia in renal transplant recipients. Curr. Opin. Urol. 10 (2000) 77-80
41. Weitz-Schmidt G., Welzenbach K., Brinkmann V., Kamata T., Kallen J., Bruns C., Cottens S., Takada Y., and Hommel U. Statins selectivity inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7 (2001) 687-692
42. + cytolytic T lymphocyte differentiation by a cholinergic pathway. J. Neuroimmunol. 164 (2005) 66-75